It is not BS. It is very good legal advice, that they not put anything, absolutely nothing, until their analysis is absolutely complete and their initial statement will not in any way contradict their further statements. It is a complex trial, and the need to get it right avoids not just the potential for nuisance suits by plaintiff’s lawyers at a critical time, but also both the FDA and SEC are very focused on these kinds of statements. So it is normal and prudent to be extremely careful and quiet during this period until they are ready.
Sure, there is no legal instruction to be quiet, in law, specifically. But the consequences of not being quiet can lead to all sorts of nonsense and distraction. And no one needs any of that at this time.
News 
Market Data 
Discover 
AI
